Summary:

Increment:

Polyclonal Antibody to Apelin (APLN)

PAD066Hu02 | Homo sapiens (Human)

XNPEP2; APEL; APJ endogenous ligand
Recombinant Apelin (APLN)

RPD066Hu02 | Homo sapiens (Human)

XNPEP2; APEL; APJ endogenous ligand
Polyclonal Antibody to Apelin (APLN)

PAD066Mu01 | Mus musculus (Mouse)

XNPEP2; APEL; APJ endogenous ligand
Polyclonal Antibody to Apelin (APLN)

PAD066Mu02 | Mus musculus (Mouse)

XNPEP2; APEL; APJ endogenous ligand
Monoclonal Antibody to Apelin (APLN)

MAD066Ra21 | Rattus norvegicus (Rat)

XNPEP2; APEL; APJ endogenous ligand
Recombinant Apelin (APLN)

RPD066Mu01 | Mus musculus (Mouse)

XNPEP2; APEL; APJ endogenous ligand
Recombinant Apelin (APLN)

RPD066Mu02 | Mus musculus (Mouse)

XNPEP2; APEL; APJ endogenous ligand
Synthetic Apelin (APLN)

SPD066Hu01 | Homo sapiens (Human)

XNPEP2; APEL; APJ endogenous ligand
OVA Conjugated Apelin (APLN)

CPD066Hu21 | Homo sapiens (Human)

XNPEP2; APEL; APJ endogenous ligand
Polyclonal Antibody to Apelin (APLN)

PAD066Hu03 | Homo sapiens (Human)

XNPEP2; APEL; APJ endogenous ligand
2/3 < > 123